Prevalence of hepatitis C virus infection among patients with hypertrophic cardiomyopathy

Heart and Vessels

Volumn 18, Issue 4, 2003, Pages 167-170

  Teragaki, Masakazu ^a,b   Nishiguchi, Shuhei ^a   Takeuchi, Kazuhide ^a   Yoshiyama, Minoru ^a   Akioka, Kaname ^a   Yoshikawa, Junichi ^a  

^a Osaka Prefecture University   (Japan)

^b Wakakusa Daiichi Hospital   (Japan)

Author keywords

Apical hypertrophy; Echocardiography; Genotype analysis; Hepatitis C virus; Hypertrophic cardiomyopathy

Indexed keywords

VIRUS RNA;

ADULT; ANTIBODY TITER; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; GENOTYPE; HEART VENTRICLE HYPERTROPHY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SEROPREVALENCE; SEROTYPE;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CARDIOMYOPATHY, HYPERTROPHIC; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY; FEMALE; HEMODYNAMIC PROCESSES; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; PREVALENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL;

EID: 0141961888     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-003-0705-0     Document Type: Article

References (28)

1. Zignego AL, Brochot C (1999) Extrahepatic manifestations of HCV infection: fact and controversies. J Hepatol 31:369-376
2. Watanabe H, Ono T, Muso E, Matsumori A, Sasayama S (2000) Hepatitis C virus infection manifesting as tubulointestinal nephritis, cardiomyopathy, and hepatitis. Am J Med 109:176-177
3. Nagao Y, Sata M, Ide T, Suzuki H, Tanikawa K, Itoh K, Kameyama T (1996) Quantitative analysis of HCV RNA and genotype in patients with chronic hepatitis C accompanied by oral lichen planus. Eur J Clin Invest 426:1171-1174
4. Herrero C, Vicente A, Bruguera M, Ercilla MG, Barrera JM, Vidal J, Teres J, Mascaro JM, Rodes J (1993) Is hepatitis C infection a trigger of porphyria cutanea tarda? Lancet 341:788-789
5. Jorgensen C, Legouffe MC, Perney P, Coste J, Tissot B, Segarra C, Bologna C, Bourrat L, Combe B, Blanc F, Sany J (1996) Sicca syndrome-associated with hepatitis C virus-infection. Arthritis Rheum 39:1166-1171
6. Ferri C, Caracciolo F, Zignego AL, La Civita L, Monti M, Longombardo G, Lombardini F, Greco F, Capochiani E, Mazzoni A (1994) Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 88:392-394
7. Matsumori A, Matoba Y, Sasayama S (1995) Dilated cardiomyopathy associated with hepatitis C virus infection. Circulation 92:2519-2525
8. Okabe M, Fukuda K, Arakawa K, Kikuchi M (1997) Chronic variant of myocarditis associated with hepatitis C virus infection. Circulation 96:22-24
9. Trepo C, Pradat P (1999) Hepatitis C virus infection in Western Europe. J Hepatol 31 Suppl 1:80-83
10. Palitzsch KD, Hottentrager B, Schlottmann K, Frick E, Holstege A, Scholmerich J, Jilg W (1999) Prevalence of antibodies against hepatitis C virus in the adult German population. Eur J Gastroenterol Hepatol 11:1215-1220
11. Moriya T, Koyama T, Tanaka J, Mishiro, S, Yoshizawa H (1999) Epidemiology of hepatitis C virus in Japan. Intervirology 42:153-158
12. Wasley A, Alter MJ (2000) Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 20:1-16
13. Baldo V, Floreani A, Menegon T, Angiolelli G, Trivello R (2000) Prevalence of antibodies against hepatitis C virus in the elderly: a seroepidemiological study in a nursing home and in an open population. The Collaborative Group. Gerontology 46:194-198
14. Matsumori A, Ohashi N, Hasegawa K, Sasayama S, Eto T, Imaizumi T, Izumi T, Kawamura K, Kawana M, Kimura A, Kitabatake A, Matsuzaki M, Nagai R, Tanaka H, Hiroe M, Hori M, Inoko H, Seko Y, Sekiguchi M, Shimotohno K, Sugishita Y, Takeda N, Takihara K, Tanaka M, Yokoyama M, et al (1998) Hepatitis C virus infection and heart disease: a multicenter study in Japan. Jpn Circ J 62:389-391
15. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies (1996) Circulation 93:841-842
16. Klues HG, Schiffers A, Maron BJ (1995) Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 26:1699-1708
17. Iwasaki Y, Esumi M, Hosokawa N, Yanai M, Kawano K (2000) Occasional infection of hepatitis C virus occurring in haemodialysis units identified by serial monitoring of the virus infection. J Hosp Infect 45: 54-61
18. Chouela E, Abeldano A, Panetta J, Ducard M, Neglia V, Sookoian S, Kina M, Castano G, Vereytou F, Frider B (1996) Hepatitis C virus antibody (anti-HCV): prevalence in psoriasis. Int J Dermatol 35:797-799
19. Nishiguchi S, Kuroki T, Ueda T, Fukuda K, Takeda T, Nakajima S, Shiomi S, Kobayashi K, Otani S, Hayashi N (1992) Detection of hepatitis C virus antibody in the absence of viral RNA in patients with autoimmune hepatitis. Ann Intern Med 116: 21-25
20. Kleinbaum D, Kupper L, Morgenstern H (1982) Epidemiologic research: principles and quantitative methods. Van Nostrand Reinhold, New York
21. Kahn HA, Sempos CT (1989) Statistical methods in epidemiology. Oxford University Press, New York
22. Sakamoto T, Tei C, Murayama M, Ichiyasu H, Hada Y (1976) Giant T-wave inversion as a manifestation of asymmetrical apical hypertrophy (AAH) of the left ventricle. Echocardiographic and ultrasonocardiotomographic study. Jpn Heart J 17: 611-629
23. Yamaguchi H, Ishimura T, Nishiyama S, Nagasaki F, Nakanishi S, Takatsu F, Nishijo T, Umeda T, Machii K (1979) Hypertrophic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy): ventriculographic and echocardiographic features in 30 patients. Am J Cardiol 44:401-412
24. Matsumori A, Ohashi N, Nishio R, Kakio T, Hara M, Furukawa Y, Ono K, Shioi T, Hasegawa K, Sasayama S (1999) Apical hypertrophic cardiomyopathy and hepatitis C virus infection. Jpn Circ J 63:433-438
25. Matsumori A, Furukawa Y, Hasegawa K, Sato Y, Nakagawa H, Morioka Y, Miura K, Ohno Y, Tamakoshi A, Inaba Y, Sasayama S (2002) Epidemiologic and clinical characteristics of cardiomyopathies in Japan: results from nationwide surveys. Circ J 66:323-336
26. Matsumori A, Matoba Y, Nishio R, Shioi T, Ono K, Sasayama S (1996) Detection of hepatitis C virus RNA from the heart of patients with hypertrophic cardiomyopathy. Biochem Biophys Res Commun 222:678-682
27. Tsuchihara K, Hijikata M, Fukuda K, Kuroki T, Yamamoto N, Shimotohno K (1999) Hepatitis C virus core protein regulates cell growth and signal transduction pathway transmitting growth stimuli. Virology 258:100-107
28. Wang Y, Su B, Sah VP, Brown JH, Han J, Chien KR (1998) Cardiac hypertrophy induced by mitogen-activated protein kinase 7, a specific activator for c-Jun NH2-terminal kinase in ventricular muscle cells. J Biol Chem 273:5423-5426